Study of Blood Platelets in Sickle Cell Disease
NCT00226083 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2015-06-09
Summary
We are studying if sickle cell disease blood platelets are larger than normal and how they may cause obstruction of blood vessels. We are also trying to study the reasons why large platelets are found in patients with sickle cell disease.
Conditions
Sponsors & Collaborators
-
Icahn School of Medicine at Mount Sinai
collaborator OTHER -
Schneider Children's Hospital of North Shore
collaborator OTHER -
Rockefeller University
lead OTHER
Principal Investigators
-
Arun Shet, MD · Rockefeller University
Eligibility
- Min Age
- 7 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-08-31
- Primary Completion
- 2007-09-30
- Completion
- 2007-09-30
Countries
- United States
Study Locations
More Related Trials
-
Exhaled Carbon Monoxide as a Marker of Hemolysis in Sickle Cell Disease- an Exploratory Study
NCT01888614 ·Status: WITHDRAWN
-
Anticoagulation For Pulmonary Hypertension in Sickle Cell Disease
NCT01036802 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Evaluate Safety, Pharmacokinetic, and Biological Activity of INCB059872 in Subjects With Sickle Cell Disease
NCT03132324 ·Status: TERMINATED ·Phase: PHASE1
-
Hemostasis in Sickle Cell Disease--Infancy to Adulthood
NCT00005703 ·Status: COMPLETED
-
Sickle Cell Disease: A Retrospective Chart Review
NCT01441375 ·Status: COMPLETED
-
CSL200 Gene Therapy in Adults With Severe Sickle Cell Disease
NCT04091737 ·Status: TERMINATED ·Phase: PHASE1
-
Neutrophil Extracellular Traps and Sickle Cell Disease
NCT02004808 ·Status: UNKNOWN
-
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901 ·Status: COMPLETED
-
Study of Beet Juice for Patients With Sickle Cell Anemia
NCT02162225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase 1 Study of Zoledronic Acid in Sickle Cell Disease
NCT00639392 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Peripheral Blood Stem Cell Collection From Patients With Sickle Cell Disease (SCD) Using Plerixafor
NCT04817345 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Impact of Oxidative Stress on Erythrocyte Biology
NCT04028700 ·Status: TERMINATED ·Phase: PHASE2
-
Role of Inflammasome in Platelet Activation in Sickle Cell Disease Patient
NCT06986837 ·Status: COMPLETED
-
Role of Placenta Growth Factor in Sickle Acute Chest Syndrome
NCT00448370 ·Status: COMPLETED
-
Blood Sampling for Research Related to Sickle Cell Disease
NCT00542230 ·Status: RECRUITING
-
Topical Sodium Nitrite in Sickle Cell Disease and Leg Ulcers
NCT02863068 ·Status: TERMINATED ·Phase: PHASE2
-
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
NCT03685721 ·Status: RECRUITING
-
A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension
NCT00850369 ·Status: WITHDRAWN ·Phase: PHASE2
-
Voxelotor Brain Oxygenation and Neurocognitive Study
NCT05228821 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study of Oral L-citrulline in Sickle Cell Disease
NCT02659644 ·Status: WITHDRAWN ·Phase: PHASE1
-
Venous Thrombosis Biomarkers in Sickle Cell Disease and Sickle Cell Trait
NCT04349189 ·Status: COMPLETED
-
Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease
NCT03977532 ·Status: COMPLETED ·Phase: NA
-
Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease
NCT00252122 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients
NCT02565082 ·Status: COMPLETED ·Phase: NA